- Home
- PRGO vs WNS Comparison
PRGO vs WNS Comparison
Compare PRGO & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- WNS
- Stock Information
- Founded
- PRGO 1887
- WNS 1996
- Country
- PRGO Ireland
- WNS India
- Employees
- PRGO N/A
- WNS N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- WNS Business Services
- Sector
- PRGO Health Care
- WNS Consumer Discretionary
- Exchange
- PRGO Nasdaq
- WNS Nasdaq
- Market Cap
- PRGO 3.4B
- WNS 2.8B
- IPO Year
- PRGO 1991
- WNS N/A
- Fundamental
- Price
- PRGO $25.32
- WNS $66.58
- Analyst Decision
- PRGO Buy
- WNS Buy
- Analyst Count
- PRGO 3
- WNS 9
- Target Price
- PRGO $33.00
- WNS $62.89
- AVG Volume (30 Days)
- PRGO 1.6M
- WNS 821.4K
- Earning Date
- PRGO 05-06-2025
- WNS 04-24-2025
- Dividend Yield
- PRGO 4.57%
- WNS N/A
- EPS Growth
- PRGO N/A
- WNS N/A
- EPS
- PRGO N/A
- WNS 2.70
- Revenue
- PRGO $4,373,400,000.00
- WNS $1,315,456,000.00
- Revenue This Year
- PRGO $3.47
- WNS N/A
- Revenue Next Year
- PRGO $2.30
- WNS $7.90
- P/E Ratio
- PRGO N/A
- WNS $24.68
- Revenue Growth
- PRGO N/A
- WNS 1.07
- 52 Week Low
- PRGO $23.14
- WNS $39.85
- 52 Week High
- PRGO $33.46
- WNS $72.11
- Technical
- Relative Strength Index (RSI)
- PRGO 43.20
- WNS 58.10
- Support Level
- PRGO $23.71
- WNS $58.56
- Resistance Level
- PRGO $25.57
- WNS $68.18
- Average True Range (ATR)
- PRGO 1.05
- WNS 4.17
- MACD
- PRGO -0.19
- WNS 0.17
- Stochastic Oscillator
- PRGO 35.86
- WNS 59.19
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a Global provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), and South Africa.